About Us

Establishment of Larix

Larix International is a private limited company involved in publishing Open Access Science and medicine related journals. The company is run by a team of dedicated editors, reviewers and authors. Over the years, Larix has evolved into one of forerunner in the publishing industry around the world. We continue to lead through the visions of technology, people, and innovation.

Why to publish with Larix?

At present, Larix International scope is to publish high-quality original research papers, case reports and other manuscripts. We promote scientific research with the help of stringent Peer-Review process. We are empowered by eminent group of editors and reviewers. The Editorial Board oversee the stringent multi-level Peer-Review process including evaluating submissions, selecting reviewers and assessing their comments and making editorial decisions.

We foster the open-access policy strongly and offer unrestricted access to the papers published, reproduction and distribution of the manuscripts in any medium, provided the original work is properly cited.

We are dedicated to offer researchers a broad range of services and are well known for providing online publication in an efficient and effective manner.

Vision of Larix

Larix wishes to establish a future trend for growth advancement in science, medicine and technology with the help of scholarly manuscripts. We wish to promote Open Access to facilitate the research literatures available on the public domain free-of-cost and to permit reading or downloading for any lawful purpose.

Mission of Larix

Larix works with a mission to publish, discuss and analyze invaluable research, applications and expert opinions in the versatile field of science, medicine and technology. We aim to bring important scientific works to a wide international audience and therefore only publish original papers with strong and analytical messages that advance our understanding of scientific principles. We ensure that the research presented in the manuscripts must be descriptive, providing insights into scope of the journal.

Editors-in-Chief


Editors

Dr . Mohammad Alzabi . Ph.D, SLP, HAAD, DHA, SCF
Neuro-Speech Pathology
Neuro-Speech Pathology
United Arab Emirates
Dr . Deepika Sandeep
Innovation Strategy
Indian Institute of Technology
India
Dr . Osinakachi Akuma Kalu Akuma Kalu
Founder & Secretary TAFFD's
TAFFD's
Georgia
Dr . Peet DuToit DuToit
Associate Professor
University of Pretoria
South Africa
Dr . Joel I. Osorio, MD (Dr. Jois)
professor
Universidad Westhill
Chicago
Dr . Alejandro De la Parra-Solomon
professor
WAMS, The World Academy of Medical Sciences
Mexico
Dr . Walter Bini
Chairman and Vice President
ISLASS Health point Hospital
UAE
Ms . Suchi Deshpande
Happiness Strategist
and Laughter Coach
Singapore